Cabaletta Bio Inc. (CABA)
NASDAQ: CABA
· Real-Time Price · USD
1.71
0.06 (3.64%)
At close: Aug 15, 2025, 3:59 PM
1.70
-0.58%
After-hours: Aug 15, 2025, 04:12 PM EDT
3.64% (1D)
| Bid | 1.6 |
| Market Cap | 156.41M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -126.76M |
| EPS (ttm) | -2.71 |
| PE Ratio (ttm) | -0.63 |
| Forward PE | -0.6 |
| Analyst | Buy |
| Ask | 1.76 |
| Volume | 1,185,406 |
| Avg. Volume (20D) | 2,131,237 |
| Open | 1.65 |
| Previous Close | 1.65 |
| Day's Range | 1.63 - 1.72 |
| 52-Week Range | 0.99 - 6.26 |
| Beta | 2.74 |
About CABA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CABA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CABA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Cabaletta Bio Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-25.53%
Cabaletta Bio shares are trading lower after the c...
Unlock content with
Pro Subscription
3 months ago
+39.23%
Cabaletta Bio shares are trading higher after the company announced its eyeing a 2027 BLA submission for rese-cel in myositis after aliging with the FDA on registrations cohorts.
1 week ago · fool.com
Cabaletta Bio (CABA) Q2 Loss Widens 30%Cabaletta Bio (CABA) Q2 Loss Widens 30%
